Cannabis, CBD and Dementia: What the Evidence Shows

Can cannabis or CBD oil help with dementia or its symptoms? Here's what the research actually shows, the safety concerns for older adults, and what to ask the doctor before anyone tries it.

By Jim Pavlish, Editor · Last updated: November 2, 2026 · Editorial policy

Short answer: there is no evidence that cannabis or CBD oil can stop, slow, reverse or prevent dementia, according to the Alzheimer's Society. A 2021 Cochrane review of four small, short trials (126 people) found cannabinoids had little or no effect on memory and thinking, and it was uncertain whether they help behavior symptoms. Sleepiness was more common. The FDA warns CBD can cause liver injury and interact with other medicines, so talk to the doctor first.

CBD oils, gummies and creams are sold almost everywhere, often with big promises. If you care for someone with dementia, especially someone who is agitated, anxious or not sleeping, it's natural to wonder whether they could help.

Here's what the research actually shows, in plain language.

This page is general information, not medical advice. Don't start, stop or change any medicine or product for someone with dementia without talking to their doctor or pharmacist.

Cannabis, THC and CBD: what's the difference?

Cannabis (also called marijuana) is a plant that contains many active compounds. The two best known are:

• THC (tetrahydrocannabinol): the part that causes the "high."
• CBD (cannabidiol): a compound that doesn't cause a high or intoxication.

There are also synthetic cannabinoids, man-made drugs that act like THC. One example is nabilone, a prescription drug used for severe nausea from chemotherapy.

The FDA has approved only one CBD product, a prescription drug (Epidiolex) for certain rare seizure disorders. It has not approved CBD for dementia or any memory problem.

Can cannabis or CBD treat or prevent dementia?

No research has shown that it can. The Alzheimer's Society says there are no studies that prove cannabis or CBD oil can stop, slow, reverse or prevent the diseases that cause dementia. The Alzheimer Society of Canada likewise says there is currently no evidence that cannabis is useful for treating or preventing Alzheimer's.

Where does the hope come from? Mostly from the lab. The Alzheimer's Society notes that some studies found parts of cannabis, including THC, seemed to clear amyloid protein from nerve cells grown in dishes, and that mice given THC and CBD learned better and had fewer amyloid clumps. Early evidence also hints that CBD may reduce brain inflammation, but this hasn't been shown in people.

Lab and mouse results often don't hold up in humans. The Alzheimer's Society points out that no studies have tested whether cannabis affects the underlying causes of Alzheimer's in people.

What about behavior symptoms like agitation?

This is where most of the research has focused. A few small trials have tested THC or synthetic cannabinoids for symptoms such as agitation and aggression.

In 2021, a Cochrane review, one of the most careful types of evidence summary, looked at every randomized trial it could find. It included just four trials with 126 people, mostly with Alzheimer's disease, lasting only 3 to 14 weeks. The reviewers found:

• Memory and thinking: cannabinoids had little or no effect.
• Behavior and mood symptoms: results were mixed. Nursing staff reported some improvement, but family caregivers did not. Overall, there may be little or no meaningful effect.
• Side effects: sleepiness and lethargy were more common with the drug nabilone.
• Certainty: low to very low, because the trials were small, short and different from each other.

The reviewers concluded it is uncertain whether cannabinoids help or harm people with dementia, and that even if the benefits are real, they may be too small to matter. Bigger, longer trials are needed.

One of the trials, from Canada, gave nabilone to 39 people with moderate to severe Alzheimer's and agitation, mostly in long-term care. Agitation scores improved compared with placebo, but sedation was much more common (45% of people on nabilone vs. 16% on placebo). The researchers said nabilone may help agitation but that sedation and thinking should be closely watched.

The Alzheimer's Society adds that some studies used high concentrations of CBD that may not be available to buy, and that none tell us about long-term effects.

Safety concerns for older adults

The FDA warns people not to assume CBD "can't hurt." Its known risks include:

• Liver injury, which may only show up on blood tests.
• Drug interactions. CBD can change how other medicines work, raising the chance of side effects or making them less effective. Many people with dementia take several medicines.
• Extra drowsiness when combined with alcohol or with medicines for anxiety, panic, stress or sleep, which can lead to injuries. For an older person, drowsiness can mean a higher risk of falls. See Preventing Falls in Dementia.
• Other side effects, such as diarrhea, lower appetite, irritability and agitation.

The FDA also says many CBD products don't contain the amount of CBD their label claims, and some may contain contaminants or THC. It has warned companies to stop claiming CBD can treat serious diseases, including Alzheimer's.

And there's a memory concern. Both the Alzheimer's Society and the Alzheimer Society of Canada note that some research links heavy, long-term cannabis use with memory problems.

If you're considering it

If someone you care for is agitated, anxious or not sleeping, the first step is to look for a cause. Pain, infection, constipation, hunger, a noisy room or a medicine side effect can all trigger distress. See Treating Behavioral Symptoms and Agitation and Aggression.

If you still want to ask about cannabis or CBD:

1. Talk to the doctor or pharmacist first. Bring the product, or a photo of its label, and a list of all medicines and supplements.
2. Ask about interactions with every medicine they take, especially anything for sleep, anxiety or mood.
3. Ask what to watch for, such as sleepiness, unsteadiness, confusion or changes in appetite.
4. Be wary of claims. Any product promising to treat, reverse or prevent dementia is making a claim no research supports. See Supplements and Memory Claims.

Common questions

Does CBD oil help dementia?

There's no evidence that CBD oil can stop, slow or reverse dementia. The Alzheimer's Society says there have been no clinical trials of cannabis or CBD oil itself in people with dementia, and studies of related compounds have been small and short.

Can cannabis help agitation in Alzheimer's?

Possibly, in some people, but the evidence is weak. A 2021 Cochrane review of four small trials found little or no clear effect on behavior symptoms overall. One trial of nabilone found less agitation, but much more sedation.

Is CBD safe for older adults?

Not automatically. The FDA warns that CBD can cause liver injury, interact with other medicines and cause drowsiness, especially with alcohol or sleep and anxiety medicines. Always check with the doctor or pharmacist first.

Does marijuana cause memory loss?

The Alzheimer's Society and the Alzheimer Society of Canada note that some research links heavy, long-term cannabis use with memory and thinking problems. More research is needed.

The bottom line

Cannabis and CBD aren't proven to treat or prevent dementia, and the small amount of research on behavior symptoms is uncertain. They also carry real risks for older adults, including drowsiness, falls and drug interactions. If you're curious, talk it through with the doctor, and look first for the everyday causes of distress that can often be fixed.

Sources

1. Alzheimer's Society: Cannabis, CBD oil and dementia
2. Cochrane (2021): Bosnjak Kuharic D et al., Cannabinoids for the treatment of dementia
3. U.S. Food and Drug Administration: What You Need to Know About Products Containing Cannabis or Cannabis-derived Compounds, Including CBD
4. Alzheimer Society of Canada: Cannabis and the treatment of dementia
5. American Journal of Geriatric Psychiatry (2019): Herrmann N et al., Randomized placebo-controlled trial of nabilone for agitation in Alzheimer's disease (PubMed 31182351)

Not medical advice. This article is general information, not a diagnosis or treatment plan for any individual. Talk with a doctor about your situation.

Related articles

• Treating Behavioral Symptoms
• Agitation and Aggression
• Anxiety in Dementia: Signs, Causes and How to Help
• Supplements and Memory Claims
• Medications That Can Affect Memory
• Managing Medications for Someone with Dementia